USE OF THE OLFACTOMEDIN 4 PROTEIN (OLFM4) IN COLORECTAL CANCER DIAGNOSIS

摘要

The present invention provides a method for diagnosing KRAS mutations in colorectal cancers by measuring the level of OLFM4. In another aspect the present invention relates a method of predicting the responds to a chemotherapeutic agent of a subject suffering from a colorectal cancer: according to the present invention the by determining the OLFM4 levels. According to the present invention the response can be predicted by determining the OLFM4 levels. This result in turn permits the design or the adaptation of a treatment of the said subject with the said chemotherapeutic agent.